Antitrust Antitrust

Sham-litigation probe of Sanofi-owned Genzyme closed in Brazil

By Ana Paula Candil
  • 17 Jun 2020 13:32
  • 17 Jun 2020 13:32
A probe of Sanofi-owned Genzyme Corp. and subsidiary Genzyme do Brasil, under which they were accused of launching sham litigation to block competitors in the market for drugs that treat high phosphate levels in the blood, was closed today by the Brazilian competition authority's Tribunal.
Members of the Tribunal of

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Ana Paula Candil

Senior Correspondent, Latin America

Ana Paula joined MLex in Brazil in 2014 writing about antitrust investigations and merger reviews. Prior to that, she worked for several trade publications and in TV. She lived in Washington DC, where she worked for Al Jazeera English in 2010. She studied journalism and holds a postgraduate diploma in International Business Management from the George Brown College in Toronto and a Master of Business Administration diploma in government relations from Fundação Getúlio Vargas (FGV).

Discover MLex

Stay on top of global regulatory developments

Latest News